Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 35.26T | 35.38T | 14.18T | 13.25T | 25.75T | 11.59T |
Gross Profit | 15.57T | 15.57T | 14.22T | 13.25T | 20.84T | 11.59T |
EBITDA | 7.55T | 7.31T | 7.15T | 7.37T | 6.49T | 0.00 |
Net Income | 4.62T | 4.45T | 4.37T | 4.67T | 4.02T | 3.41T |
Balance Sheet | ||||||
Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Cash, Cash Equivalents and Short-Term Investments | 10.00T> | 10.00T> | 10.00T> | 94.21T | 94.37T | 92.87T |
Total Debt | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
Stockholders Equity | 56.82T | 56.05T | 53.72T | 50.73T | 47.29T | 44.07T |
Cash Flow | ||||||
Free Cash Flow | 6.86T | 3.85T | -186.39B | 6.65T | 10.19T | -5.05T |
Operating Cash Flow | 7.52T | 4.63T | 1.91T | 7.59T | 11.08T | -4.41T |
Investing Cash Flow | -552.16B | 148.53B | -4.27T | -11.03T | -12.03T | -3.03T |
Financing Cash Flow | 492.25B | -182.65B | 8.38T | 3.39T | 4.96T | 7.88T |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $18.81B | 12.17 | 16.35% | 5.89% | 3.89% | 15.26% | |
72 Outperform | $27.38B | 7.35 | 10.66% | 3.04% | 18.54% | 28.34% | |
71 Outperform | $12.67B | 6.43 | 9.43% | 4.24% | 22.26% | 2.51% | |
71 Outperform | $23.77B | 7.31 | 8.79% | 2.57% | 28.42% | 4.76% | |
70 Outperform | $17.78B | 17.42 | 9.43% | 6.37% | -3.94% | 31.52% | |
66 Neutral | $27.72B | 8.23 | 11.76% | 2.20% | -4.58% | 39.03% | |
65 Neutral | £5.10B | 9.36 | 5.51% | 4.90% | 24.59% | -22.68% |